Less Ads, More Data, More Tools Register for FREE

Pin to quick picksIDH.L Regulatory News (IDH)

  • There is currently no data for IDH

Pre-close Trading update

30 Mar 2006 07:01

Immunodiagnostic Systems Hldgs PLC30 March 2006 Immunodiagnostic Systems Holdings plc Pre-close Trading Update Immunodiagnostic Systems Holdings plc ("IDS" or the "Group"), a leading producerof diagnostic testing kits for the clinical and research markets, announces atrading update prior to the close of its trading year to 31st March 2006. David Evans, Chairman of IDS stated: "Trading for the year to 31 March 2006 is in line with market expectations. IDS has achieved impressive growth in the year to 31 March 2006 as a result of: • the continued success of the Group's direct distribution in the key territories of the UK, USA, Germany and, most recently, France. • the expansion of the Group's export distribution network. • the successful integration of the Bone TRAP products into the Group's distribution channels following the acquisition of SBA in March 2005. • the greater emphasis placed on selling the Group's own products and the successful displacement of a key competitor's products in Vitamin D which has positively impacted margin. The Board remains confident for continued growth during 2006/07 and furtherdetails will be given when the Group announces its preliminary results in July." Enquiries: IDS Holdings plc Binns & Co PR Ltd David Evans, Chairman Roger Duggan, Managing Director Paul McManusTel: 07740 084 452 Tel: 0191 519 6109 Tel: 020 7786 9600 Mob: 07980 541 893 This information is provided by RNS The company news service from the London Stock Exchange
Date   Source Headline
6th Dec 20182:59 pmRNSDirector/PDMR Shareholding
23rd Nov 20185:04 pmRNSHalf-year Report
19th Oct 20185:18 pmRNSH1 Trading Update
4th Sep 20188:00 amRNSCompletion of Share Buyback
30th Aug 20187:00 amRNSProposed Share Buyback
7th Aug 20185:48 pmRNSTransaction in Own Shares
7th Aug 20187:00 amRNSTransaction in Own Shares
1st Aug 20186:06 pmRNSTransaction in Own Shares
31st Jul 20186:02 pmRNSTransaction in Own Shares
26th Jul 20185:59 pmRNSResult of AGM
26th Jul 20187:00 amRNSAGM Statement
11th Jul 20185:33 pmRNSTransaction in Own Shares
20th Jun 20187:05 amRNSPublication of Annual Report and Accounts
20th Jun 20187:00 amRNSFinal Results
13th Jun 20185:07 pmRNSTransaction in Own Shares
6th Jun 20188:04 amRNSTransaction in Own Shares
20th Apr 20184:35 pmRNSTrading Statement
12th Apr 20185:21 pmRNSTransaction in Own Shares
6th Apr 20185:47 pmRNSTransaction in Own Shares
5th Apr 20182:16 pmRNSTransaction in Own Shares
29th Mar 20186:25 pmRNSDirector/PDMR Shareholding
29th Mar 20186:21 pmRNSDirector/PDMR Shareholding
29th Mar 20181:32 pmRNSLaunch of two new automated assays
29th Mar 20187:00 amRNSTransaction in Own Shares
26th Mar 20185:08 pmRNSTransaction in Own Shares
23rd Mar 20183:59 pmRNSTransaction in Own Shares
21st Mar 20185:50 pmRNSDirectorate Change
21st Mar 20181:08 pmRNSDirector/PDMR Shareholding
1st Mar 20184:50 pmRNSTransaction in Own Shares
22nd Feb 20185:02 pmRNSTransaction in Own Shares
21st Feb 20185:30 pmRNSTransaction in Own Shares
15th Feb 20185:20 pmRNSTransaction in Own Shares
13th Feb 201812:13 pmRNSTransaction in Own Shares
12th Feb 20181:22 pmRNSTransaction in Own Shares
6th Feb 20184:49 pmRNSTransaction in Own Shares
5th Feb 20183:19 pmRNSTransaction in Own Shares
2nd Feb 20182:47 pmRNSTransaction in Own Shares
24th Jan 20181:21 pmRNSTransaction in Own Shares
16th Jan 20187:00 amRNSPartnership Agreement with Technogenetics
15th Jan 20184:45 pmRNSTransaction in Own Shares
27th Dec 20175:16 pmRNSTransaction in Own Shares
24th Nov 20174:30 pmRNSHalf-year Report
23rd Nov 20175:15 pmRNSTransaction in Own Shares
14th Nov 201712:06 pmRNSTransaction in Own Shares
13th Nov 20175:37 pmRNSTransaction in Own Shares
2nd Nov 20176:05 pmRNSTransaction in Own Shares
1st Nov 20174:29 pmRNSAdditional Listing
1st Nov 20174:05 pmRNSTransaction in Own Shares
31st Oct 20176:22 pmRNSDirectorate Change
31st Oct 20176:03 pmRNSTransaction in Own Shares

Due to London Stock Exchange licensing terms, we stipulate that you must be a private investor. We apologise for the inconvenience.

To access our Live RNS you must confirm you are a private investor by using the button below.